Groundbreaking research from Switzerland uncovers a significant gender gap in beta blocker effectiveness, finding women experience a far greater reduction in mortality following a heart attack than men.
Groundbreaking research finds beta-blockers significantly improve survival rates and reduce heart failure in women post-heart attack, challenging previous assumptions about gender-neutral treatment efficacy.
Groundbreaking research from Sweden indicates beta-blocker therapy significantly improves long-term survival rates in women who have suffered a heart attack, challenging current prescription trends.
Groundbreaking UK research reveals a cheap, widely available heart drug, propranolol, could significantly improve survival rates for women battling aggressive triple-negative breast cancer, offering new hope for a notoriously difficult-to-treat disease.
Experts warn that free VPN services may secretly harvest your personal data while promising online privacy. Learn how to stay safe.